Product Images Pimecrolimus

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Pimecrolimus NDC 0591-2944 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The Structural formula of pimecrolimus is (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(1E)-2-{(1R,3R,4S)-4-chloro-3-methoxycyclohexyl}-1-methylvinyl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-aza-tricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetraone. The compound has the molecular formula C43H68CINO11 and the molecular weight of 810.47. - pimecrolimus cream a209345 1

Figure 1 depicts the time course of improvement in the percent body surface area affected as a result of treatment with pimecrolimus cream, 1% in 2 to 17 year olds. - pimecrolimus cream a209345 2

This appears to be a graph depicting the "Body Surface Area Over Time". The Y-axis denotes "% Body Surface Area Affected" with mean and 95% confidence interval values displayed. The X-axis displays the "Time (days)" label with corresponding values marked from 0 to 43. It is not clear what the units are.*

Figure 2 shows the time course of improvement in erythema as a result of treatment with pimecrolimus cream, 1% in 2 to 17 year olds. - pimecrolimus cream a209345 3

1 - pimecrolimus cream a209345 4

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.